Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 3/20 | 0.36 |
| ▸ | CTSK | P43235 | 3/20 | 0.36 |
| ▸ | CTSL | P07711 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.35 |
| ▸ | CAPN2 | P17655 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | BMP1 | P13497 | 1/20 | 0.35 |
| ▸ | REN | P00797 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6982715 | 0.94 | CYP1A2 (0.37) | CTSSCTSKCTSLCYP1A2MEN1 | |
| SCHEMBL6981709 | 0.89 | BMP1 (0.38) | MMP2BMP1REN | |
| SCHEMBL6982041 | 0.83 | BMP1 (0.39) | MMP2BMP1REN | |
| SCHEMBL6984595 | 0.82 | CYP1A2 (0.37) | CTSSCTSKCTSLCYP1A2 | |
| SCHEMBL6981390 | 0.81 | BMP1 (0.37) | MMP2BMP1REN | |
| SCHEMBL6987232 | 0.81 | BMP1 (0.37) | MEN1KMT2AMMP2BMP1REN | |
| SCHEMBL6983470 | 0.77 | BMP1 (0.39) | CTSLMMP2BMP1REN | |
| SCHEMBL6982858 | 0.76 | MMP1 (0.38) | CTSLREN | |
| SCHEMBL6983113 | 0.76 | CYP1A2 (0.36) | CTSSCTSKCTSLCYP1A2MEN1 | |
| SCHEMBL6986123 | 0.76 | CTSS (0.36) | CTSSCTSKCTSLCYP1A2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1089964-B1 | HYDRAZINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2003-10-29 | — | — | EP | disclosed |
| US-6239151-B1 | TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES, OSTEOARTHRITIS, RESPIRATORY DISEASES, TUMORS, CACHEXIA, CARDIOVASCULAR DISEASES, FEVER, HAEMORRHAGE AND SEPSIS, HYDRAZINE DERIVATIVES, | HOFFMANN-LA ROCHE INC. | 2001-05-29 | — | — | US | disclosed |